(Q42287342)

19 October 2017

Oseltamivir resistance during treatment of H7N9 infection (English)

1 reference

19 October 2017

1 reference

2

Frederick G Hayden

1 reference

19 October 2017

Alan J Hay

1

1 reference

PubMed ID

23809549

19 October 2017

language of work or name

English

0 references

publication date

1 June 2013

1 reference

19 October 2017

1 reference

19 October 2017

381

1 reference

19 October 2017

9885

1 reference

19 October 2017

2230-2232

1 reference

Human infection with a novel avian-origin influenza A (H7N9) virus

19 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961209-X

7 January 2021

Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961209-X

7 January 2021

The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961209-X

7 January 2021

Resistant influenza A viruses in children treated with oseltamivir: descriptive study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961209-X

7 January 2021

Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961209-X

7 January 2021

Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961209-X

7 January 2021

Oseltamivir resistance during treatment of influenza A (H5N1) infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961209-X

7 January 2021

Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961209-X

7 January 2021

Determinants of antiviral effectiveness in influenza virus A subtype H5N1.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961209-X

7 January 2021

Effectiveness of antiviral treatment in human influenza A(H5N1) infections: analysis of a Global Patient Registry.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961209-X

7 January 2021

Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A(H1N1) virus pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961209-X

7 January 2021

Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961209-X

7 January 2021

Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961209-X

7 January 2021

Adjunctive therapies and immunomodulatory agents in the management of severe influenza

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961209-X

7 January 2021

Clinical findings in 111 cases of influenza A (H7N9) virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961209-X

7 January 2021

Poor responses to oseltamivir treatment in a patient with influenza A (H7N9) virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961209-X

7 January 2021

Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961209-X

7 January 2021

Antiviral therapy and outcomes of patients with pneumonia caused by influenza A pandemic (H1N1) virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961209-X

7 January 2021

Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961209-X

7 January 2021

Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961209-X

7 January 2021

10.1016/S0140-6736(13)61209-X

Identifiers

DOI

1 reference

release_ujv5eh4uy5h45bljaiag4rjh2y

19 October 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ujv5eh4uy5h45bljaiag4rjh2y

24 November 2022

mapped directly with Wikidata item

PubMed ID

23809549

1 reference

PubMed ID

23809549